Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Rodolfo Chicas-Sett

Has grant

Faculty

Hospital Universitari i Politècnic La Fe

Spain

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Recent Grants

Grant: Close

Radio-Inmunoterapia en cáncer metastásico

Open Date: 2020-11-01

Close Date: 2022-11-01

Articles (11)

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Manel Juan

Head of Immunology service/department

Hospital Clínic de Barcelona

SPAIN

View details

Isabel Barragan

Pharmacologist and Geneticist. Nicolas Monardes Programme Senior Researcher, Group Leader

Karolinska Institutet

SWEDEN

View details

Delvys Rodriguez-Abreu

Universidad de Las Palmas de Gran Canaria

SPAIN

View details

Ana Arance

University of Barcelona

SPAIN

View details

Luis Alvarez-Vallina

Group Leader and Director of the Advanced Therapy Programme

Institut Hospital del Mar d'Investigacions Mèdiques

SPAIN

View details

Pedro C. Lara

SPAIN

View details

Jose Carlos Benitez

Instituto de Investigación Biomédica de Málaga

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rodolfo Chicas-Sett

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (11)

Abstracts of the XII Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 12)

Abstracts of the XI Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 11)

Dose-Escalated SBRT for Borderline and Locally Advanced Pancreatic Cancer: Resectability Rate and Pathological Results of a Multicenter Prospective Study

Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer

Impact of a glutamine-enriched peptide formula on gastrointestinal toxicity and on the interruption of oncologic treatment in patients with adenocarcinoma of the rectum

162: DOSE-ESCALATED SBRT IN ADVANCED PANCREATIC CANCER. FEASIBILITY, SAFETY: PRELIMINARY CLINICAL RESULTS

Dose-escalated SBRT for borderline and locally advanced pancreatic cancer. Feasibility, safety and preliminary clinical results of a multicenter study

PO-1404 Hyperthermia with short-course-Radiotherapy in TNT for LARC: Initial outcomes and toxicity

Prospective Pilot study of Quality of Life in patients with severe late-radiation-toxicity treated by Low hyperbaric-oxigen-therapy

Stereotactic ablative radiotherapy for acquired resistance to EGFR therapy in metastatic non-small cell lung cancer

Combination of Stereotactic Ablative Radiotherapy and Systemic Therapy in Oligoprogressive Non-small Cell Lung Cancer

Collaborators (7)

Manel Juan

Isabel Barragan

Delvys Rodriguez-Abreu

Ana Arance

Luis Alvarez-Vallina

Pedro C. Lara

Jose Carlos Benitez

Make your next move.